Corporate News Pfizer to sell remaining stake in Haleon by Contributor since / Followers 4 days ago JHVEPhoto/iStock Editorial via Getty Images Pfizer (NYSE:PFE) is planning to sell 662M shares of Haleon (NYSE:HLN) to divest its remaining stake in the U.K.-based consumer healthcare company, Bloomberg News reported Tuesday, citing Citigroup (C) which serves as a joint global Tags: PFE Continue Reading Previous Boeing’s cash flow peak will limit gains for stock, Wells Fargo saysNext Trump administration follows Biden in defending 340B drug-discount program Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment. Δ